Direct targeting for focused ultrasound thalamotomy in the treatment of movement disorders: a retrospective cohort study.

Accurate targeting of the ventral intermediate nucleus (Vim) remains a critical challenge in stereotactic thalamotomy for essential tremor (ET) and tremor-dominant Parkinson's disease (TDPD). Indirect atlas-based methods suffer from interindividual anatomical variability and poor visualization of thalamic substructures. We evaluated the clinical impact of a direct targeting strategy enabled by fast gray matter acquisition T1 inversion recovery (FGATIR) imaging in MR-guided focused ultrasound (MRgFUS) thalamotomy. We conducted a retrospective cohort study of adult patients who underwent first-time MRgFUS thalamotomy for ET or TDPD at the Oregon Health and Sciences University (Portland, Oregon) between August 2023 and January 2024. Patients treated with FGATIR-guided direct targeting (n=64, male=40) were matched to a cohort treated using indirect targeting combined with physiological mapping (n=52, male=36). Data was collected from intraoperative recordings and postprocedural imaging, as well as one-day, one-month, and three-month follow-up evaluations. Procedural efficiency, lesion and edema characteristics, tract involvement, clinical outcomes, and adverse events were assessed. FGATIR-guided direct targeting significantly reduced the number of sonications (-22%), total sonication time (-32%), and overall procedural duration (-33%) compared to indirect targeting. Lesion volumes and perilesional edema were smaller in the direct targeting group with less impingement on the internal capsule and medial lemniscus. Direct targeting had higher initial sonication accuracy with a lower incidence of neurologic deficits. Both groups achieved similar tremor improvements. FGATIR-based direct targeting improves the safety, precision, and efficiency of MRgFUS thalamotomy without compromising clinical benefit. The FGATIR sequence is widely available on clinical MRI systems, and this method may be adapted for use with other targets for stereotactic ablation in functional neurosurgery. Direct targeting represents a scalable and patient-centered advancement for stereotactic thalamotomy with minimal technological barriers to widespread adoption. OHSU Parkinson Center Pilot Program; Oregon Medical Research Foundation #1029114.